연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1786 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Rapid quantitative high-throughput mouse embryoid body model for embryotoxicity assessment | Park, Seung-Chun | Park, SC | 8 | Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu 41566, South Korea | AAV-3388-2021 | Park, Seung-Chun | lee.seungjin@kitox.re.kr;yuwj@kitox.re.kr; | |||
| Rapid quantitative high-throughput mouse embryoid body model for embryotoxicity assessment | Lee, Seung-Jin | Lee, SJ | 9 | 교신저자 | Korea Inst Toxicol, Dev & Reprod Toxicol Res Grp, Daejeon 34114, South Korea | CAI-2335-2022 | Lee, Jun Young | 0000-0001-7109-6423 | Lee, Seung-Jin | lee.seungjin@kitox.re.kr;yuwj@kitox.re.kr; |
| Rapid quantitative high-throughput mouse embryoid body model for embryotoxicity assessment | Yu, Wook-Joon | Yu, WJ | 10 | 교신저자 | Korea Inst Toxicol, Dev & Reprod Toxicol Res Grp, Daejeon 34114, South Korea | KJL-1295-2024 | Yu, Wook-Joon | lee.seungjin@kitox.re.kr;yuwj@kitox.re.kr; | ||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Lim, Myong Cheol | Lim, MC | 1 | |||||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Kim, Ji Hyun | Kim, JH | 2 | AFT-1305-2022 | Kim, ji hyun | |||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Park, Boram | Park, B | 3 | |||||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Lee, Jung-Yun | Lee, JY | 4 | ITU-1407-2023 | Lee, YuRim | |||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Chang, Suk-Joon | Chang, SJ | 5 | |||||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Lee, Yoo-Young | Lee, YY | 6 | ABA-8808-2020 | Lee, Yoon | |||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Choi, Chel Hun | Choi, CH | 7 | AAS-3301-2021 | Choi, Youn | |||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Park, Jeong-Yeol | Park, JY | 8 | W-5046-2019 | Park, Jeong-Yeol | |||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Kim, Dae-Yeon | Kim, DY | 9 | |||||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Hong, Dae Gy | Hong, DG | 10 | |||||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Cho, Hyun-Woong | Cho, HW | 11 | |||||||
| Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) | Song, Jae-Yun | Song, JY | 12 |
페이지 이동: